Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ASML Holding N.V. Interim / Quarterly Report 2020

Apr 15, 2020

3813_iss_2020-04-15_3bf416fc-2f14-4362-8d28-310e9b00683f.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

ASML - Summary US GAAP Consolidated Statements of Operations

Three months ended,
Mar 31, Mar 29,
2019 2020
(unaudited, in millions EUR, except per share data)
Net system sales 1,689.0 1,584.0
Net service and field option sales 540.1 856.6
Total net sales 2,229.1 2,440.6
Total cost of sales (1,301.1) (1,339.2)
Gross profit 928.0 1,101.4
Research and development costs (472.7) (544.0)
Selling, general and administrative costs (121.0) (130.7)
Income from operations 334.3 426.7
Interest and other, net (7.9) (11.4)
Income before income taxes 326.4 415.3
Benefit from (provision for) income taxes 17.0 (48.5)
Income after income taxes 343.4 366.8
Profit (loss) related to equity method investments 12.0 23.8
Net income 355.4 390.6
Basic net income per ordinary share 0.84 0.93
Diluted net income per ordinary share 0.84 0.93
Weighted average number of ordinary shares used in computing per share amounts (in millions):
Basic 421.1 419.0
Diluted 422.5 419.7

ASML - Ratios and Other Data

Three months ended,
Mar 31, Mar 29,
2019 2020
(unaudited, in millions EUR, except otherwise indicated)
Gross profit as a percentage of net sales 41.6 % 45.1%
Income from operations as a percentage of net sales 15.0 % 17.5%
Net income as a percentage of net sales 15.9 % 16.0%
Income taxes as a percentage of income before income taxes (5.2)% 11.7%
Shareholders' equity as a percentage of total assets 58.8 % 53.8%
Sales of lithography systems (in units) 1 48 57
Value of booked systems (EUR millions) 2 1,399 3,085
Net bookings lithography systems (in units) 1, 2 34 73
Number of payroll employees in FTEs 21,461 23,860
Number of temporary employees in FTEs 2,395 1,467

1 Lithography systems do not include metrology and inspection systems.

2 Our systems net bookings include all system sales orders for which written authorizations have been accepted (for EUV excluding the High-NA systems).

ASML - Summary US GAAP Consolidated Balance Sheets

Dec 31, Mar 29,
2019 2020
(unaudited, in millions EUR)
ASSETS
Cash and cash equivalents 3,532.3 2,723.7
Short-term investments 1,185.8 1,388.1
Accounts receivable, net 1,786.8 1,767.4
Finance receivables, net 564.5 748.7
Current tax assets 178.7 529.0
Contract assets 231.0 292.1
Inventories, net 3,809.2 4,345.3
Other assets 842.8 905.8
Total current assets 12,131.1 12,700.1
Finance receivables, net 421.1 340.8
Deferred tax assets 445.3 482.3
Other assets 830.4 902.3
Equity method investments 833.0 865.1
Goodwill 4,541.1 4,541.1
Other intangible assets, net 1,104.4 1,082.5
Property, plant and equipment, net 1,999.3 2,046.9
Right-of-use assets - Operating 205.4 197.1
Right-of-use assets - Finance 118.5 119.4
Total non-current assets 10,498.5 10,577.5
Total assets 22,629.6 23,277.6
LIABILITIES AND SHAREHOLDERS' EQUITY
Total current liabilities 4,694.1 4,677.4
Long-term debt 3,108.3 3,868.2
Deferred and other tax liabilities 234.4 262.7
Contract liabilities 1,759.6 1,702.6
Accrued and other liabilities 241.0 241.5
Total non-current liabilities 5,343.3 6,075.0
Total liabilities 10,037.4 10,752.4
Total shareholders' equity 12,592.2 12,525.2
Total liabilities and shareholders' equity 22,629.6 23,277.6

ASML - Summary US GAAP Consolidated Statements of Cash Flows

Three months ended,
Mar 31, Mar 29,
2019 2020
(unaudited, in millions EUR)
CASH FLOWS FROM OPERATING ACTIVITIES
Net income 355.4 390.6
Adjustments to reconcile net income to net cash flows from
operating activities:
Depreciation and amortization 104.8 118.3
Impairment 2.7 2.7
Loss on disposal of property, plant and equipment 0.6 1.0
Share-based payments 14.9 14.9
Allowance for obsolete inventory 72.1 39.3
Deferred income taxes (76.5) (24.6)
Equity method investments (17.0) (32.3)
Changes in assets and liabilities (937.8) (1,115.7)
Net cash provided by (used in) operating activities (480.8) (605.8)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment (147.0) (231.5)
Purchase of intangible assets (86.7) (10.8)
Purchase of short-term investments (288.1) (310.5)
Maturity of short-term investments 179.4 108.2
Repayment on loans 0.3
Net cash provided by (used in) investing activities (342.4) (444.3)
CASH FLOWS FROM FINANCING ACTIVITIES
Purchase of shares (52.6) (507.5)
Net proceeds from issuance of shares 5.2 8.6
Net proceeds from issuance of notes, net of issuance costs 739.8
Repayment of debt (0.7) (0.9)
Net cash provided by (used in) financing activities (48.1) 240.0
Net cash flows (871.3) (810.1)
Effect of changes in exchange rates on cash 3.2 1.5
Net increase (decrease) in cash and cash equivalents (868.1) (808.6)
Cash and cash equivalents at beginning of the period 3,121.1 3,532.3
Cash and cash equivalents at end of the period 2,253.0 2,723.7

ASML - Quarterly Summary US GAAP Consolidated Statements of Operations

Three months ended,
Mar 31, June 30, Sep 29, Dec 31, Mar 29,
2019 2019 2019 2019 2020
(unaudited, in millions EUR, except per share data)
Net system sales 1,689.0 1,850.8 2,325.6 3,130.7 1,584.0
Net service and field option sales 540.1 717.1 660.9 905.7 856.6
Total net sales 2,229.1 2,567.9 2,986.5 4,036.4 2,440.6
Total cost of sales (1,301.1) (1,462.7) (1,680.1) (2,096.3) (1,339.2)
Gross profit 928.0 1,105.2 1,306.4 1,940.1 1,101.4
Research and development costs (472.7) (487.4) (492.3) (516.1) (544.0)
Selling, general and administrative costs (121.0) (123.5) (128.5) (147.6) (130.7)
Income from operations 334.3 494.3 685.6 1,276.5 426.7
Interest and other, net (7.9) (6.9) (5.4) (4.8) (11.4)
Income before income taxes 326.4 487.4 680.2 1,271.7 415.3
Benefit from (provision for) income taxes 17.0 (19.1) (65.0) (124.5) (48.5)
Income after income taxes 343.4 468.3 615.2 1,147.2 366.8
Profit (loss) related to equity method investments 12.0 7.7 11.6 (13.1) 23.8
Net income 355.4 476.0 626.8 1,134.1 390.6
Basic net income per ordinary share 0.84 1.13 1.49 2.70 0.93
Diluted net income per ordinary share 0.84 1.13 1.49 2.69 0.93
Weighted average number of ordinary shares used in computing per share amounts (in millions):
Basic 421.1 421.1 420.9 420.1 419.0
Diluted 422.5 421.8 421.7 421.1 419.7

ASML - Quarterly Summary Ratios and other data

Mar 31,
2019
June 30,
2019
Sep 29,
2019
Dec 31,
2019
Mar 29,
2020
(unaudited, in millions EUR, except otherwise indicated)
Gross profit as a percentage of net sales 41.6 % 43.0% 43.7% 48.1% 45.1%
Income from operations as a percentage of net sales 15.0 % 19.2% 23.0% 31.6% 17.5%
Net income as a percentage of net sales 15.9 % 18.5% 21.0% 28.1% 16.0%
Income taxes as a percentage of income before income taxes (5.2)% 3.9% 9.6% 9.8% 11.7%
Shareholders' equity as a percentage of total assets 58.8 % 57.6% 58.3% 55.6% 53.8%
Sales of lithography systems (in units) 1 48 48 57 76 57
Value of booked systems (EUR millions) 2 1,399 2,828 5,111 2,402 3,085
Net bookings lithography systems (in units) 1, 2, 3 34 61 81 60 73
Number of payroll employees in FTEs 21,461 22,125 22,805 23,219 23,860
Number of temporary employees in FTEs 2,395 2,157 1,913 1,681 1,467

1 Lithography systems do not include metrology and inspection systems.

2 Our systems net bookings include all system sales orders for which written authorizations have been accepted (for EUV excluding the High-NA systems).

3 Our Q3 2019 systems net bookings include 1 DUV system shipped to collaborative Research Center (Imec) in Q3 2019. This system is not recognized in revenue.

Mar 31, June 30, Sep 29, Dec 31, Mar 29,
2019 2019 2019 2019 2020
(unaudited, in millions EUR)
ASSETS
Cash and cash equivalents 2,253.0 1,661.1 1,586.1 3,532.3 2,723.7
Short-term investments 1,022.1 673.5 483.8 1,185.8 1,388.1
Accounts receivable, net 1,589.3 1,637.7 2,100.7 1,786.8 1,767.4
Finance receivables, net 534.6 620.1 584.9 564.5 748.7
Current tax assets 373.3 320.9 339.6 178.7 529.0
Contract assets 103.5 190.4 287.8 231.0 292.1
Inventories, net 3,764.8 3,914.1 3,895.0 3,809.2 4,345.3
Other assets 755.7 877.5 816.2 842.8 905.8
Total current assets 10,396.3 9,895.3 10,094.1 12,131.1 12,700.1
Finance receivables, net 399.4 406.3 588.2 421.1 340.8
Deferred tax assets 280.7 326.6 309.2 445.3 482.3
Other assets 881.1 893.3 951.2 830.4 902.3
Equity method investments 933.6 949.9 969.0 833.0 865.1
Goodwill 4,541.1 4,541.1 4,541.1 4,541.1 4,541.1
Other intangible assets, net 1,158.5 1,140.8 1,122.8 1,104.4 1,082.5
Property, plant and equipment, net 1,621.8 1,669.8 1,817.9 1,999.3 2,046.9
Right-of-use assets - Operating 148.1 154.8 227.2 205.4 197.1
Right-of-use assets - Finance 56.0 78.5 118.5 119.4
Total non-current assets 9,964.3 10,138.6 10,605.1 10,498.5 10,577.5
Total assets 20,360.6 20,033.9 20,699.2 22,629.6 23,277.6
LIABILITIES AND SHAREHOLDERS' EQUITY
Total current liabilities 3,721.2 3,692.5 3,712.5 4,694.1 4,677.4
Long-term debt 3,082.5 3,132.4 3,170.0 3,108.3 3,868.2
Deferred and other tax liabilities 218.6 199.6 203.6 234.4 262.7
Contract liabilities 1,190.0 1,280.2 1,276.5 1,759.6 1,702.6
Accrued and other liabilities 182.6 183.9 265.5 241.0 241.5
Total non-current liabilities 4,673.7 4,796.1 4,915.6 5,343.3 6,075.0
Total liabilities 8,394.9 8,488.6 8,628.1 10,037.4 10,752.4
Total shareholders' equity 11,965.7 11,545.3 12,071.1 12,592.2 12,525.2
Total liabilities and shareholders' equity 20,360.6 20,033.9 20,699.2 22,629.6 23,277.6

ASML - Quarterly Summary US GAAP Consolidated Balance Sheets

ASML - Quarterly Summary US GAAP Consolidated Statements of Cash Flows

Three months ended,
Mar 31, June 30,
Sep 29,
Dec 31, Mar 29,
2019 2019 2019 2019 2020
(unaudited, in millions EUR)
CASH FLOWS FROM OPERATING ACTIVITIES
Net income 355.4 476.0 626.8 1,134.1 390.6
Adjustments to reconcile net income to net cash flows from
operating activities:
Depreciation and amortization 104.8 108.4 112.4 122.9 118.3
Impairment 2.7 2.0 2.7
Loss on disposal of property, plant and equipment 0.6 1.4 0.3 0.8 1.0
Share-based payments 14.9 12.5 18.0 29.2 14.9
Allowance for obsolete inventory 72.1 49.1 46.1 54.2 39.3
Deferred income taxes (76.5) (65.1) 22.5 (80.9) (24.6)
Equity method investments (17.0) (15.3) (18.6) 107.8 (32.3)
Changes in assets and liabilities (937.8) (467.5) (740.1) 2,220.2 (1,115.7)
Net cash provided by (used in) operating activities (480.8) 99.5 69.4 3,588.3 (605.8)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment (147.0) (128.3) (185.8) (305.5) (231.5)
Purchase of intangible assets (86.7) (11.7) (11.2) (9.7) (10.8)
Purchase of short-term investments (288.1) (0.7) (100.3) (902.4) (310.5)
Maturity of short-term investments 179.4 349.3 290.0 200.3 108.2
Repayment on loans 0.9 0.3
Net cash provided by (used in) investing activities (342.4) 208.6 (7.3) (1,016.4) (444.3)
CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid (884.4) (441.3)
Purchase of shares (52.6) (17.4) (148.4) (191.6) (507.5)
Net proceeds from issuance of shares 5.2 7.4 7.4 7.2 8.6
Net proceeds from issuance of notes, net of issuance costs 739.8
Repayment of debt (0.7) (1.2) (1.0) (0.9) (0.9)
Net cash provided by (used in) financing activities (48.1) (895.6) (142.0) (626.6) 240.0
Net cash flows (871.3) (587.5) (79.9) 1,945.3 (810.1)
Effect of changes in exchange rates on cash 3.2 (4.4) 4.9 0.9 1.5
Net increase (decrease) in cash and cash equivalents (868.1) (591.9) (75.0) 1,946.2 (808.6)
Cash and cash equivalents at beginning of the period 3,121.1 2,253.0 1,661.1 1,586.1 3,532.3
Cash and cash equivalents at end of the period 2,253.0 1,661.1 1,586.1 3,532.3 2,723.7

Notes to the Summary US GAAP Consolidated Financial Statements

Basis of preparation

The accompanying unaudited Summary Consolidated Financial Statements have been prepared in conformity with the accounting principles generally accepted in the United States of America ("US GAAP").

For further details on our annual disclosure requirements under US GAAP, including our significant accounting policies, these interim unaudited Summary Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and Notes included within our 2019 Integrated Report based on US GAAP, which is available on www.asml.com.

Forward Looking Statements

This document contains statements that are forward-looking, including statements with respect to expected trends, outlook, bookings, financial results and effective tax rate, annual revenue opportunity in 2020 and through 2025 and long term growth opportunity including the expectation that 2020 will be a growth year, expected trends in end markets, products and segments, including memory and logic, expected industry and business environment trends, the expected continuation of Moore's law and the expectation that EUV will continue to enable Moore's law and drive long term value for ASML and statements with respect to plans regarding dividends and share buybacks, including the dividend proposal in respect of 2019, the intention to continue to return excess cash to shareholders through a combination of share buybacks and growing annualized dividends and the new share buyback program. You can generally identify these statements by the use of words like "may", "will", "could", "should", "project", "believe", "anticipate", "expect", "plan", "estimate", "forecast", "potential", "intend", "continue", "target", and variations of these words or comparable words. These statements are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our business and our future financial results and readers should not place undue reliance on them. Forward-looking statements do not guarantee future performance and involve risks and uncertainties. These risks and uncertainties include, without limitation, economic conditions; product demand and semiconductor equipment industry capacity; worldwide demand and manufacturing capacity utilization for semiconductors; the impact of general economic conditions on consumer confidence and demand for our customers' products; performance of our systems, the success of technology advances and the pace of new product development and customer acceptance of and demand for new products; the number and timing of systems ordered, shipped and recognized in revenue, and the risk of order cancellation or push out, production capacity for our systems including delays in system production; our ability to enforce patents and protect intellectual property rights and the outcome of intellectual property disputes and litigation; availability of raw materials, critical manufacturing equipment and qualified employees; trade environment; changes in exchange and tax rates; available liquidity, our ability to refinance our indebtedness, available cash and distributable reserves for, and other factors impacting, dividend payments and share repurchases, results of the share repurchase programs and other risks indicated in the risk factors included in ASML's Annual Report on Form 20-F and other filings with and submissions to the US Securities and Exchange Commission. These forward-looking statements are made only as of the date of this document. We do not undertake to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.